American Society of Hematology

Fig. 6.

$Fig. 6. Low TRECs are associated with the development of OIs. / TRECs per 106 PBMCs were measured and plotted (y-axis) for patients who had developed severe OIs (○, dashed line) or not (▪, solid line) as a function of the time from transplantation. All severe OIs are represented in A (P ≤ .01; CMV is included only for chronic or refractory viremia; see also Table 2). (B) This panel includes any CMV antigenemia and/or end-organ CMV disease (P = .05). Note that the lower limit of detection for TRECs was 100 TRECs/106 PBMCs in the assay used.$

Low TRECs are associated with the development of OIs.

TRECs per 10⁶ PBMCs were measured and plotted (y-axis) for patients who had developed severe OIs (○, dashed line) or not (▪, solid line) as a function of the time from transplantation. All severe OIs are represented in A (P ≤ .01; CMV is included only for chronic or refractory viremia; see also Table 2). (B) This panel includes any CMV antigenemia and/or end-organ CMV disease (P = .05). Note that the lower limit of detection for TRECs was 100 TRECs/10⁶ PBMCs in the assay used.

This Feature Is Available To Subscribers Only